Castle V, Andrew M, Kelton J. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749–55.Google Scholar
Roberts IA, Murray NA. Thrombocytopenia in the newborn. Curr Opin Pediatr 2003;15:17–23.Google Scholar
Marraffa J, Guharoy R, Duggan D, Rose F, Nazeer S. Vancomycin-induced thrombocytopenia: a case proven with rechallenge. Pharmacotherapy 2003;23:1195–8.Google Scholar
Dilek DŞ, Suna Oğuz UD. A newborn with vancomycin-induced thrombocytopenia. Pharmacology 2008;82:285–6.Google Scholar
Shah RA, Musthaq A, Khardori N. Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report. J Med Case Rep 2009;3:7290.Google Scholar
Warkentin T. Drug-induced immune-mediated thrombocytopenia – from purpura to thrombosis. New Engl J Med 2007;356:891–3.Google Scholar
Drygalski A, Curtis B, Bougie D, McFarland J, Ahl S, Limbu I, et al. Vancomycin-induced immune thrombocytopenia. New Engl J Med 2007;356:904–10.Google Scholar
Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 2007;60:1361–9.Google Scholar
About the article
Published Online: 2016-11-16
Published in Print: 2016-12-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.